Ledger.Open graph →

SEC Form D · Amendment · filed July 20, 2023

Life Sciences Innovation Fund II, L.P

Offering

—

Sold

$10.8M

Exemption

Rule 506(b)

Industry

Pooled Investment Fund

Location

NEW YORK, NY

Type

Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Todd Wheatley · Lowell, MAExec · Director Tyler Deveraux · Ocoee, FLExec · Director David Sable · New York, NYExec · Director Adam M. Stettner · New York, NYExec · Director AWM Investment Company, Inc · New York, NYExec Matthew Perimian · Lowell, MAExec · Director Life Sciences Innovation GP LLC · New York, NYExec · Director Austin W. Marxe · New York, NYExec · Director David M. Greenhouse · New York, NYExec · Director R. M. Chavez · Dallas, TXExec · Director Life Sciences Innovation GP LLC · New York, NYExec · Director Al J. Landon · Las Cruces, NMExec · Director Dennis L. Pahlisch · Bend, ORExec · Director AWM Investment Company, Inc · New York, NYExec Ryan Woolley · Ocoee, FLExec · Director Brian Weiner · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗